Researchers discover a crucial gene involved in the development of the placenta

July 17, 2017, Institute for Research in Biomedicine (IRB Barcelona)
Embryos lacking TLK2 (left) appear morphologically normal but developmentally delayed. Credit: S. Segura-Bayona, IRB Barcelona

A massive genomics study of people with intellectual disabilities performed in the Netherlands points to patient mutations in the TLK2 gene.

The placenta, a transient organ that links the developing embryo to its mother, is responsible for nutrient, waste and gas exchange between the foetus and the mother. Scientists at the Institute for Research in Biomedicine (IRB Barcelona) reveal that the TLK2 gene is vital for the development of the placenta and for embryo viability in mice. The results are published today in the journal Cell Death and Differentiation, a publication of the Nature group.

In spite of the difference between in mice and humans, this finding may be of biomedical relevance. Recent clinical data obtained from a massive genomic analysis of people with undertaken in the Netherlands detected mutations in 10 new genes, among them TLK2.

Travis H. Stracker, researcher at IRB Barcelona and head of the study, says, "We propose that mutations in the TLK2 gene in humans could result in impaired placental function during embryo development. Placental defects could result in insufficient oxygen during development and cause neurological disorders."

Mice depleted of TLK2 produce a smaller embryo and placenta than normal mice; however, the researchers did not observe morphological defects. Defects in the placenta were found to cause embryo death at day 15 of a 20-day gestation period. The scientists detected a reduction in the expression of genes that are crucial for the differentiation of trophoblasts—a group of specialised cells that supply the embryo with nutrients—and that this reduction impairs the function of the placenta.

A non-essential gene in adults

In this study, the scientists also unveil that TLK2 is non-essential in adult mice. Its "twin" gene TLK1 substitutes for its loss. The absence of one of these genes is compensated by the presence of the other and the animals are normal and healthy and have the same life expectancy.

Placental development is defective in the absence of TLK2 (above). Credit: S. Segura-Bayona, IRB Barcelona

"It is only when we simultaneously remove both genes that we observe genomic instability, such as chromosome segregation defects or chromosomal aberrations," explains the "la Caixa" PhD student at IRB Barcelona, Sandra Segura-Bayona. She appears as first author of the study together with postdoctoral fellow Philip Knobel, and former student Helena González Burón, who started this study under a "la Caixa" fellowship in 2011 and whose thesis results are included in this article.

The researchers conclude that TLK1 and TLK2 conserve genomic integrity and cell viability and that they have largely redundant functions in adults.

TLK1 and TLK2 in cancer

In the field of cancer, it is known that TLK2 shows increased expression in a subtype of breast tumour and that this increase contributes to cancer progression. Furthermore, TLK1 and TLK2 are involved in cell proliferation, and the activity of these two genes is believed to be necessary for the growth of tumour cells. Given these considerations, both TLK1 and TLK2 may be potential anti-cancer targets.

To address this question, Stracker's lab, which is devoted to studying the relationship between Genomic Instability and Cancer, is working towards the identification of TLK1 and TLK2 inhibitors in order to examine the function of these in models of cancer.

Explore further: Researchers discover new signaling pathway in embryonic development

More information: Sandra Segura-Bayona et al. Differential requirements for Tousled-like kinases 1 and 2 in mammalian development, Cell Death and Differentiation (2017). DOI: 10.1038/cdd.2017.108

Related Stories

Researchers discover new signaling pathway in embryonic development

March 11, 2015
During pregnancy, the mother supplies the fetus with nutrients and oxygen via the placenta. If placental development is impaired, this may lead to growth disorders of the embryo or to life-threatening diseases of the mother ...

New possible target for cancer treatment

June 6, 2017
Scientists at Karolinska Institutet in Sweden report that cancer cells and normal cells use different 'gene switches' in order to regulate the expression of genes that control growth. In mice, the removal of a large regulatory ...

Mom's in control—even before you're born

January 25, 2016
Researchers have uncovered previously unappreciated means by which epigenetic information contained in the egg influences the development of the placenta during pregnancy. The research, which was performed in mice, indicates ...

Recommended for you

Unprecedented study identifies 44 genetic risk factors for major depression

April 26, 2018
A global research project has mapped out the genetic basis of major depression, identifying 44 genetic variants which are risk factors for depression, 30 of which are newly discovered. The study, by the Psychiatric Genomics ...

Key differences in young, older people's immune cells attributed to environment

April 26, 2018
Discoveries by Stanford University School of Medicine investigators may help explain why older people's immune systems often don't work so well, why different people's immune systems age at different rates, and why the environment ...

New testing provides better information for parents of children with form of epilepsy

April 26, 2018
Advances in genetic testing offer new insights to parents who have a child with a rare but serious form of epilepsy, epileptic encephalopathy (EE), found in one of about every 2,000 births and characterized by developmental ...

Natural barcodes enable better cell tracking

April 24, 2018
Each of us carries in our genomes about 10 million genetic variations called single nucleotide polymorphisms (SNPs), which represent a difference of just one letter in the genetic code. Every human's pattern of SNPs is unique ...

The role of 'extra' DNA in cancer evolution and therapy resistance

April 23, 2018
Glioblastoma (GBM) is the most common and aggressive form of brain cancer. Response to standard-of-care treatment is poor, with a two-year survival rate of only 15 percent. Research is beginning to provide a better understanding ...

Variants in non-coding DNA contribute to inherited autism risk

April 19, 2018
In recent years, researchers have firmly established that gene mutations appearing for the first time, called de novo mutations, contribute to approximately one-third of cases of autism spectrum disorder (ASD). In a new study, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.